What is MIMS Connect?

What is MIMS Connect?

MIMS Connect articles are provided by a selection of...

RSS Feed

Latest news

New cystic fibrosis combination drug not recommended for NHS use

New cystic fibrosis combination drug not recommended for NHS use

Orkambi (lumacaftor/ivacaftor), a new gene-specific...

Symbicort now available as metered-dose inhaler for COPD

Symbicort now available as metered-dose inhaler for COPD

Symbicort (formoterol/budesonide) is now available...

Citalopram: suspected interaction with cocaine

Citalopram: suspected interaction with cocaine

Healthcare professionals should be aware of the potential...

Anticoagulant linked to rare calciphylaxis risk

Anticoagulant linked to rare calciphylaxis risk

Calciphylaxis, a rare but serious condition causing...

Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers

Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers

Uptravi (selexipag), a prostacyclin receptor agonist...


New and deleted products

Promo Image

New Products

Products added to MIMS

Promo Image

Deleted Products

Products removed from MIMS


Latest CPD from MIMS Learning


Most popular

H.pylori: Eradication Regimens (NICE)

Summary of NICE guidance on Helicobacter treatment.

Antidepressants, a Guide to Switching and Withdrawing

Instructions for changing or stopping antidepressants.

Cystitis

Antibiotic Treatments in Adults, Summary of Regimens

Dose regimens for common bacterial infections.

Routine Childhood Immunisation Schedule

Summary of routine childhood vaccinations.


Featured MIMS resources

Promo Image

Routine childhood immunisation schedule

Quick-reference summary of the UK childhood vaccination programme.

Promo Image

Menopause: diagnosis and management

At-a-glance summary of the new NICE guidance on menopause.


Patient fact sheets

Browse the MIMS patient fact sheet library and find printable patient information on topics from acne to yellow fever.

Haemophilia

Nappy Rash

Menopause & HRT


Manufacturers

Manufacturers

Contact details and drug listings for manufacturers in MIMS


New products coming soon to MIMS

Check back soon to find MIMS listings for the following new drugs:

Alprolix (eftrenonacog alfa)

Brinavess (vernakalant)

Elocta (efmoroctocog alfa)

Epclusa (sofosbuvir/velpatasvir)

Fertavid (follitropin beta)

Flixabi (infliximab)

NovoEight (turoctocog alfa)

Obizur (susoctocog alfa)

Rixubis (nonacog gamma)

Zalviso (sufentanil)

Zinbryta (daclizumab)


Latest from MIMS Dermatology

1 CPD credit: Management of common photodermatoses

1 CPD credit: Management of common photodermatoses

A thorough history and examination are the essential...

1 CPD credit: Skin reactions to wound dressings

1 CPD credit: Skin reactions to wound dressings

Careful selection of dressings and topical agents can...

1.5 CPD credits: Non-infective skin disorders in HIV patients

1.5 CPD credits: Non-infective skin disorders in HIV patients

Awareness of the higher prevalence of skin disease...


Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.

This site is intended for healthcare professionals.